CD14 and diffuse large B-cell lymphoma: Analyses of PMN-MDSCs were also excluded from a recent study by Wang et al., in which 103 DLBCL patients (65 newly diagnosed, 12 in relapse, and 26 in remission) and 30 healthy controls were examined for M-MDSCs’ (CD14+HLADR−/low) frequencies in their peripheral blood [94].